Abstract

Objective: To improve early detection and survival in women with Hereditary Breast and Ovarian Cancer (HBOC) syndromes, national organizations have advocated the development of specialized clinics. We evaluated clinical quality outcomes related to ovarian cancer screening and risk-reduction guidelines at our institutional high-risk Prevention Assessment and Tailored Health Screening (PATHS) clinic, compared to national guidelines.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.